Vyteris
Fair Lawn · Founded 1990
About Vyteris
Vyteris is the maker of the first active drug delivery patch to receive market approval from the U.S. Food and Drug Administration (FDA). Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company (BD), to develop, manufacture, and commercialize pharmaceutical products based upon this unique, advanced drug delivery technology. BD created Transdermal Systems just prior to 1990 and invested 10 years and close to $80 million in developing the basis of the Vyteris transdermal drug delivery system.
Company Facts
- Founded: 1990
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $1.1M
- Last round: Debt Financing (Jul 2011)
- Website: http://vyteris.com
- Phone: 201-703-2299
Industries & Categories
Health Care, Manufacturing, Pharmaceutical
Canonical: https://fsome.com/organization/vyteris-2406516 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.